Form 4 for DXCM Dexcom

Accepted 2023-01-20 00:00:00 ET · period of report 2023-01-18 · accession 0001093557-23-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
	2023-01-20	2023-01-18	DXCM	SAYER KEVIN R	Pres CEO, COB of, Dir	A - Grant	$0.00	+90.7K	472.3K	+24%	$0
	2023-01-20	2022-11-03	DXCM	SAYER KEVIN R	Pres CEO, COB of, Dir	G - Gift	$0.00	-10.0K	381.5K	-3%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-18	A	A	90,720	$0.00	472,252	D	—	—	(F3) Represents performance stock units ("PSUs") granted to the reporting person on March 8, 2020 that vested on January 18, 2023, with the applicable performance achieved. (F2) Included in this number are 134,792 unvested restricted stock units, 65,004 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 35,852 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 33,936 of which were granted on March 8, 2020 and shall vest through March 8, 2023.
2	Common	Common Stock	2022-11-03	G	D	10,000	$0.00	381,532	D	—	—	(F1) The transaction represents a gift by the Reporting Person of 10,000 shares to a charitable donor advised fund. (F2) Included in this number are 134,792 unvested restricted stock units, 65,004 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 35,852 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 33,936 of which were granted on March 8, 2020 and shall vest through March 8, 2023.